PRESS RELEASE published on 01/03/2023 at 14:30, 3 years 1 month ago Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
PRESS RELEASE published on 01/03/2023 at 14:27, 3 years 1 month ago Form 8.3 - The Vanguard Group, Inc.: Biffa plc
PRESS RELEASE published on 01/03/2023 at 14:23, 3 years 1 month ago Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Published on 03/02/2026 at 16:00, 59 minutes ago MWC 2026: Amdocs Announces Research Collaboration with Stanford Researchers to Study AI's Impact on Software Engineering Productivity
Published on 03/02/2026 at 15:22, 1 hour 37 minutes ago Silver Spruce Resources Inc. Announces Non-Brokered Private Placement for Proceeds of up to $2,000,000
Published on 03/02/2026 at 15:00, 1 hour 59 minutes ago Norsemont Targets Filing Environmental Impact Declaration in December 2026
Published on 03/02/2026 at 15:00, 1 hour 59 minutes ago Reminder: Today, March 2, 2026, is the Record Date for Jaguar Health's Special One-time Stock Dividend
Published on 03/02/2026 at 16:35, 24 minutes ago Skyhawk Announces Australia's Therapeutic Goods Administration Has Determined SKY-0515 for Huntington's Disease Meets Eligibility Criteria for Registration via the Provisional Approval Pathway
Published on 03/02/2026 at 16:25, 34 minutes ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Published on 03/02/2026 at 16:17, 42 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 03/02/2026 at 15:30, 1 hour 29 minutes ago MWC26 Barcelona opens with call to complete 5G, rise to AI challenges, and strengthen digital safety
Published on 03/02/2026 at 08:45, 8 hours 14 minutes ago Imerys: 2025 consolidated financial statements
Published on 02/27/2026 at 23:00, 2 days 17 hours ago Biophytis increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
Published on 02/27/2026 at 18:02, 2 days 22 hours ago AXA: Execution of a share repurchase agreement in relation to AXAs share buy-back program of up to Euro 1.25 billion
Published on 02/27/2026 at 17:45, 2 days 23 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2025
Published on 02/27/2026 at 17:45, 2 days 23 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of January 31, 2026
